Severe vasospasm in off-pump coronary artery bypass surgery: A difficult clinical problem  by Saxena, Pankaj et al.
autoimmune disease, and other idiopathic
causes. The degree of fibrosis determines the
clinical significance of the mediastinal le-
sions. Most patients have nonspecific symp-
toms and the mediastinal fibrosing disorder is
often discovered as an incidental radiologic
finding. Enhanced computed tomography
may be helpful in identifying the mediastinal
changes and the degree of compression of the
involved structures. There is no universally
accepted therapeutic modality for the treat-
ment of chronic fibrosing mediastinitis. Sur-
gical intervention is initially indicated in
most patients to establish a diagnosis and
particularly to rule out neoplasia. Surgical
management is also necessary to alleviate the
compression of involved structures and re-
lieve the symptoms.
We congratulate the authors on the suc-
cessful management of a difficult case.
However, in our case we could not perform
a similar operation because the diagnosis of
mycobacterial infection was established.
The mycobacteria perhaps would involve
the prosthetic vessel and induce severe in-
fection. However, medical therapy with an
antitubercular drug can be administered in
the case of positive identification of the
mycobacteria. The results also showed that
occlusion of the coronary artery along with
the involvement of other great vessels had
already disappeared with antitubercular
treatment in our patient.2
We should consider some important
points regarding similar patients with fibro-
sing mediastinitis, including the diagnosis,
relief of the vascular obstruction, and ad-
vanced therapy. Surgical management is
widely recommended for the diagnosis of
suspected cases. If the diagnosis is estab-
lished, some patients should be treated by
surgical management at the same time and
some patients should be treated with a
drug. Although some cases of the disease
may be considered idiopathic after surgical
diagnosis, fibrosing mediastinitis should be
treated surgically if the symptoms need im-
mediate relief. Otherwise, idiopathic fibro-
sing mediastinitis should first be treated by
steroids or tamoxifen rather than by ad-
vanced surgical treatment.3
The prognosis for fibrosing mediastini-
tis, generally speaking, is good with med-
ical therapy. However, the mortality of the
patients without therapy is still high and the
health of many surviving patients becomes
compromised as a result of disease progres-
sion. Fibrosing mediastinitis is still a chal-
lenge for thoracic and cardiovascular sur-
geons.
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Severe vasospasm in off-pump
coronary artery bypass surgery: A
difficult clinical problem
To the Editor:
We read with interest the article published
by Schena and associates.1 They have
highlighted the importance of vasospasm in
the nongrafted right coronary artery (RCA)
without any hemodynamically significant
disease in a patient undergoing off-pump
coronary artery bypass surgery (OPCAB)
to the diseased left-sided vessels. We2 have
had a similar experience in which initially
vasospasm developed in a normal RCA
after OPCAB to the left anterior descend-
ing (LAD) and obtuse marginal arteries.
The spasm was relieved by an intracoro-
nary injection of vasodilators. Subse-
quently, severe vasospasm involving the
left internal thoracic artery (LITA) and
LAD developed. There was no improve-
ment in myocardial ischemia despite
use of intracoronary vasodilators and an
intra-aortic balloon pump (IABP). This
patient required a drug-eluting stent
across the LITA-LAD anastomosis for
relief of the spasm (Figure 1).
The incidence of persistent vasospasm
requiring the use of intracoronary vasodi-
lators, IABP, or stents in our experience
with 677 OPCAB procedures was 0.33%.2
If there is no improvement in myocardial
ischemia despite standard measures or in
the setting of recurrent myocardial isch-
emia after OPCAB surgery, intracoronary
stents may have to be used. Coronary an-
giography should be performed promptly if
unexplained myocardial ischemia occurs in
the immediate postoperative period. An ag-
gressive approach to this problem is asso-
ciated with a satisfactory outcome.
We congratulate the authors on the suc-
cessful management of a difficult case and
Figure 1. Severe vasospasm involving LITA and LAD, including the anastomotic area (A).
Result of stent placement across the anastomosis (B). Source: Saxena P, Konstantinov IK,
Singh T, Koniuszko MD, Newman MAJ. Persistent severe vasospasm in off-pump coro-
nary artery bypass surgery: the value of intraluminal stenting. J Thorac Cardiovasc Surg.
2006;131:237-8. Reproduced with permission of Elsevier Inc.
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emphasize that stenting can be an effective
mode of treatment of persistent coronary
artery and graft vasospasm.
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Igor E Konstantinov, MD, PhD
Mark A. J. Newman, FRACS
Department of Cardiothoracic Surgery
Sir Charles Gairdner Hospital
Nedlands, WA, Australia
References
1. Schena S, Wildes T, Beardslee MA, Lasala
JM, Damiano RJ, Lawton JS. Successful
management of unremitting spasm of the
nongrafted right coronary artery after off-
pump coronary artery bypass grafting. J Tho-
rac Cardiovasc Surg. 2007;133:1649-50.
2. Saxena P, Konstantinov IE, Koniuszko M,
Singh T, Newman MAJ. Persistent severe
vasospasm in off-pump coronary artery by-
pass surgery: the value of intraluminal stent-
ing. J Thorac Cardiovasc Surg. 2006;131:
237-8.
doi:10.1016/j.jtcvs.2007.07.023
Surgery of Ebstein anomaly
To the Editor:
I read with great interest the article by
Quinonez and colleagues1 concerning sur-
gical treatment of the Ebstein anomaly.
This very informative article underlines the
role of the right ventricle in the outcome of
this congenital anomaly. As my colleagues
and I2 pointed out almost 10 years ago,
impairment of the right ventricle is a major
prognostic factor after surgery for the Eb-
stein anomaly. Inasmuch as medical ther-
apy is difficult to manage, it seemed to us
that the association of a bidirectional cavo-
pulmonary shunt (BCPS) would be helpful
in the early follow-up period. This contin-
ues to be our policy.
The term used by the authors, “1.5-
ventricle,” does not seem to me to be ade-
quate. The flow of the superior vena cava
varies between one third and one half of the
cardiac ouput.3 The 1.5-ventricle concept is
valid when one of the ventricles is anatom-
ically partially deficient.
The article by Quinonez and associates
does not answer a question that arises im-
mediately: what are the indications for the
BCPS? Their definition of “failing right
ventricle” is not clear. In their series, 2
children were free of symptom, whereas,
on the other hand, 3 adult patients were on
the transplantation list. Right ventricular
enlargement could be an indicator, but we
are still looking for quantitative data. In a
study of the right and left ventricular vol-
umes before and after surgery, my col-
leagues and I4 were unable to determine a
threshold value for patients “at risk” and
those that were “safe.” In our experience, a
large atrialized right ventricle (even if ex-
cluded after surgery), a very thin infundib-
ular right ventricular wall, and/or a para-
doxic septal motion are indications for a
superior vena cava derivation. Among 105
patients with Ebstein repair and BPCS, we
did not observe any deleterious effect of
the shunt except for a transient swelling of
the neck in 1 patient.
The BCPS does not solve all of the left
and right ventricular problems. One of the
patients in the authors’ series is not im-
proved and 2 in our own series had to
undergo transplantation.
However, the associated anastomosis is
an excellent additional procedure in pa-
tients with difficult indications.
S. Chauvaud, MD
Cardiovascular Surgery Department
Hôpital Européen Georges Pompidou
Paris, France
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Reply to the Editor:
My colleagues and I thank Dr Chauvaud
for his comments and acknowledge the
contribution of his team to the surgical
treatment of Ebstein anomaly.
The use of the term “1.5-ventricle” was
a semantic choice used to represent an op-
eration, rather than a quantitative or phys-
iologic descriptor. It is widely understood
that diversion of blood flow by a bidirec-
tional cavopulmonary shunt (BCPS) varies
from one third to one half of the systemic
venous return, depending on the patient’s
age.
To decide when to construct a BCPS,
the surgeon has to use his or her judgment
and experience and take into consideration
the patient’s clinical condition, echocardio-
graphic data, magnetic resonance imaging
data (if available), preoperative and intra-
operative hemodynamic data, and the intra-
operative morphologic appearance of the
right ventricle. The status of the left ven-
tricle is also very important. Our series is
too limited to advise as to the specific in-
dications of a BCPS in Ebstein anomaly,
yet with further experience and follow-up
these will become apparent. It is our im-
pression that it is only needed in a few
selected cases.
The term “failing right ventricle” is de-
liberately general. It may describe a right
ventricle that cannot sustain the circulation
after cardiopulmonary bypass; it may de-
scribe a right ventricle that is severely dys-
functional or dilated on echocardiography,
magnetic resonance imaging, or intraoper-
ative inspection; or it may describe a right
ventricle with a large atrialized component,
a thin wall, and paradoxical septal motion,
as pointed out by Dr Chauvaud. In any of
these circumstances, the patient may be
free of symptoms. The underlying diffi-
culty arises in the precise quantification of
right ventricular function by the currently
available methods. We are exploring the
use of magnetic resonance imaging to bet-
ter describe and quantitate the morphology
and function of the right ventricle.
Luis G. Quinonez, MD
University of Alberta Hospital
Edmonton, Alberta, Canada
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The conduct of experimental
circulatory arrest: The search for
clinical relevance
To the Editor:
I read with great interest the excellent
laboratory study by Dr Ananiadou and
colleagues1 detailing the neuroprotective
effect of profound hypothermia at 10°C
after 75 minutes of circulatory arrest in
an acute porcine model (N  12). The
described neuroprotective mechanism
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